Average cost per year*
Average cost per beneficiary*
This medication is used to help prevent migraine. This medication may work by changing the amounts of certain natural substances in the brain. Erenumab belongs to a class of drugs known as monoclonal antibodies. Preventing frequent migraine attacks can help improve your ability to concentrate and do your usual tasks. This monograph is about the following erenumab product: erenumab-aooe. NOTE: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
*Origin of the terms and chart data used within this page: https://data.cms.gov/
Yes, Aimovig Autoinjector is covered by Medicare.
In 2021, the average cost per dose of Aimovig Autoinjector was $673.76.
The average dose of Aimovig Autoinjector received per year is 187,123 units
54,670 Medicare beneficiaries received Aimovig Autoinjector in 2021, which was a 0.14% from 2020
There were 330,843 claims made by Medicare beneficiaries, which is a 0.16% from 2020
The average spending amount per claim in 2021 was $782.62
The average Medicare spending per beneficiary amount for Aimovig Autoinjector was $4,736.13
Amgen received $258,924,035.10
The total amount spent on Aimovig Autoinjector by Medicare is $258,924,035.10
Short Term Medical Insurance
Limited Fixed Indemnity Plans